Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001048477-24-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | BMRN | Davis George Eric | EVP, CLO | A - Grant | $0.00 | +10.3K | 102.2K | +11% | $0 |
| D | 2024-03-19 | 2024-03-15 | BMRN | Davis George Eric | EVP, CLO | F - Tax | $83.87 | -21.7K | 80.5K | -21% | -$1.82M |
| D | 2024-03-19 | 2024-03-15 | BMRN | Davis George Eric | EVP, CLO | A - Grant | $0.00 | +23.0K | 23.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 10,260 | $0.00 | 102,157 | D | — | — | (F1) Restricted stock units granted March 15, 2024. Price not applicable. |
| 2 | Common | Common Stock | 2024-03-15 | F | D | 21,699 | $83.87 | 80,458 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-03-15 | A | A | 22,990 | $0.00 | 22,990 | D | $83.87 · 2025-03-15 to 2034-03-14 | 22,990 Common Stock | (F2) Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter. |